It shall be unlawful for any person to retail any poisons enumerated in schedules "A" that CONTAIN:
 
I. arsenic and its preparations
II. biniodide of mercury
III. cyanide of potassium

a. I only
b. I and II only
c. All
d. None of the above

  Answer  

It shall be unlawful for any person to retail any poisons enumerated in schedules "A" that CONTAIN:
 
I. arsenic and its preparations
II. biniodide of mercury
III. cyanide of potassium

a. I only
b. I and II only
c. All
d. None of the above

Answer: None of the above - all choices can be sold at retail, [Missouri Revised Statutes (MRS) Chapter 338 Sections 338.090].
 
It shall be unlawful for any person to retail any poisons enumerated in schedules "A" and "B", EXCEPT AS FOLLOWS:
 
Schedule "A" arsenic and its preparations, biniodide of mercury, cyanide of potassium, hydrocyanic acid, strychnia, and all other poisonous vegetable alkaloids and their salts, and the essential oil of bitter almonds.
 
Schedule "B" opium and its preparations, except paregoric and other preparations of opium containing less than two grains to the ounce, aconite, bella donna, colchicum, conium, nux vomica, henbane, savin, ergot, cotton root, cantharides, creosote, veratrum, digitalis, and their pharmaceutical preparations, croton oil, chloroform, chloral hydrate, sulphate of zinc,  corrosive sublimate, red precipitate, white precipitate, mineral acids, carbolic acid, oxalic acid, without labeling the box, vessel or paper in which the said poison is contained, and also the outside wrapper or cover with the name of the article, the word "poison" and the name and place of business of the seller.
 
Nor shall it be lawful for any person to sell or deliver any poisons enumerated in schedules "A" and "B" unless, upon due inquiry, it is found that the purchaser is aware of its poisonous character and represents that it is to be used for legitimate purposes.
 
Nor shall it be lawful for any registered pharmacists to sell any poisons included in schedule "A" without, before delivering the same to the purchaser, causing an entry to be made in a book kept for that purpose, stating
 
a. the date of sale, name and address of purchaser,
b. the name of the poison sold,
c. the purpose for which it was represented by the purchaser to be required and
d. the name of the dispenser.
 
Such book to be always open for inspection by the proper authorities, and to be preserved for at least five years.
 
The provisions of this section shall not apply to the dispensing of poison in not unusual quantities or doses upon the prescription of practitioners of medicine.

  Close  

Within the electronic supervision environment, the data entry can be performed by the pharmacy student or pharmacy technician being electronically supervised.

True or False

  Answer  

Within the electronic supervision environment, the data entry can be performed by the pharmacy student or pharmacy technician being electronically supervised.

True or False

Answer: True, [Kansas Pharmacy Practice Act Article 22 Sec. 68-22-5(c)].
 
(a). A pharmacy student or pharmacy technician may enter the pharmacy without a pharmacist present for purposes of turning on the data, video, or audio links and determining if a pharmacist is available for electronic supervision.
 
(b). Electronic supervision shall not be permitted if an interruption occurs in any of the data, video, or audio links. Whenever an interruption in any of the data, video, or audio links occurs, no medication order shall be filled or dispensed using electronic supervision.
 
(c). Data entry may be performed by the electronically supervising pharmacist or the pharmacy student or pharmacy technician being electronically supervised. Each entry performed by an electronically supervised pharmacy student or pharmacy technician shall be verified by the electronically supervising pharmacist before the drug leaves the pharmacy.
 
(d). All medication orders processed by a pharmacy student or a pharmacy technician being electronically supervised shall be capable of being displayed on a computer terminal at both the location of the electronically supervising pharmacist and the medical care facility's pharmacy.
 
(e). The quality of the image viewed by the pharmacist shall be sufficient for the pharmacist to be able to determine the accuracy of the work of the pharmacy student or pharmacy technician.

  Close  

The Kansas Pharmacy Board is authorized to provide data in the prescription monitoring program to the:
 
I. An individual who requests the individual's own prescription monitoring information.
 
II. Designated representatives from the department of health and environment regarding authorized Medicaid program recipients.
 
III. Persons authorized to prescribe or dispense scheduled substances and drugs of concern, for the purpose of providing medical or pharmaceutical care for their patients.
 
a. I only
b. I and II only
c. II and III only
d. All

  Answer  

The Kansas Pharmacy Board is authorized to provide data in the prescription monitoring program to the:
 
I. An individual who requests the individual's own prescription monitoring information.
 
II. Designated representatives from the department of health and environment regarding authorized Medicaid program recipients.
 
III. Persons authorized to prescribe or dispense scheduled substances and drugs of concern, for the purpose of providing medical or pharmaceutical care for their patients.
 
a. I only
b. I and II only
c. II and III only
d. All

Answer: (d) All, [Kansas Pharmacy Practice Act Article 16 Chapter 65 Sec. 65-1685(c)].
 
The board is hereby authorized to provide data in the prescription monitoring program to the following persons:
 
(1). Persons authorized to prescribe or dispense scheduled substances and drugs of concern, for the purpose of providing medical or pharmaceutical care for their patients;
 
(2). an individual who requests the individual's own prescription monitoring information in accordance with procedures established by the board;
 
(3). designated representatives from the professional licensing, certification or regulatory agencies charged with administrative oversight of those persons engaged in prescribing or dispensing of scheduled substances and drugs of concern;
 
(4). local, state and federal law enforcement or prosecutorial officials engaged in the administration, investigation or enforcement of the laws governing scheduled substances and drugs of concern subject to the requirements in K.S.A. 22-2502 and amendments thereto;
 
(5). designated representatives from the department of health and environment regarding authorized Medicaid program recipients;
 
(6). persons authorized by a grand jury subpoena, inquisition subpoena or court order in a criminal action;
 
(7). personnel of the prescription monitoring program advisory committee for the purpose of operation of the program;
 
(8). personnel of the board for purposes of administration and enforcement of this act or the uniform controlled substances act, K.S.A. 65-4101 et seq., and amendments thereto.
 
(9). persons authorized to prescribe or dispense scheduled substances and drugs of concern, when an individual is obtaining prescriptions in a manner that appears to be misuse, abuse or diversion of scheduled substances or drugs of concern; and
 
(10). medical examiners, coroners or other persons authorized under law to investigate or determine causes of death.

  Close  

During the temporary absence of the pharmacist, only the pharmacist in charge designated pharmacy technicians or pharmacy support persons may be present in the prescription department to perform technical or nontechnical functions.

True or False

  Answer  

During the temporary absence of the pharmacist, only the pharmacist in charge designated pharmacy technicians or pharmacy support persons may be present in the prescription department to perform technical or nontechnical functions.

True or False

Answer: True, [Title 657 Iowa Administrative Code Chapter 6 Section 6.7(2)].
 
In the temporary absence of the pharmacist, only the pharmacist in charge may designate pharmacy technicians or pharmacy support persons who may be present in the prescription department to perform technical or nontechnical functions, respectively, designated by the pharmacist in charge.
 
Activities identified in subrule 6.7(3) may not be performed during such temporary absence of the pharmacist. A temporary absence is an absence of short duration not to exceed two hours.

  Close  

The board may impose the following disciplinary sanctions if it found that the pharmacist is practicing pharmacy without a current license:
 
I. Revocation of a registration, a permit, or a license issued by the board.
 
II. Suspension of a registration, a permit, or a license issued by the board until further order of the board or for a specified period.
 
III. Nonrenewal of a registration, a permit, or a license issued by the board.

a. I only
b. III only
c. I and II only
d. II and III only
e. All

  Answer  

The board may impose the following disciplinary sanctions if it found that the pharmacist is practicing pharmacy without a current license:
 
I. Revocation of a registration, a permit, or a license issued by the board.
 
II. Suspension of a registration, a permit, or a license issued by the board until further order of the board or for a specified period.
 
III. Nonrenewal of a registration, a permit, or a license issued by the board.

a. I only
b. III only
c. I and II only
d. II and III only
e. All

Answer (e) All, [Title 657 Iowa Administrative Code Chapter 36 Section 36.1(2) And Chapter 2 Section 2.11(2)].
 
If a license is not renewed before its expiration date, the license is delinquent and the licensee may not practice pharmacy in the state of Iowa until the licensee reactivates the delinquent license.
 
Reactivation of a delinquent license shall include submission of a completed application and appropriate fees and may include requirements relating to the reactivation of an inactive license pursuant to subrule 2.13(2).
 
A pharmacist who continues to practice pharmacy in Iowa without a current license may be subject to disciplinary sanctions pursuant to the provisions of 657—subrule 36.1(2).
 
657—subrule 36.1(2):
 
a. Revocation of a registration, a permit, or a license issued by the board.
 
b. Suspension of a registration, a permit, or a license issued by the board until further order of the board or for a specified period.
 
c. Nonrenewal of a registration, a permit, or a license issued by the board.
 
d. Prohibit permanently, until further order of the board, or for a specified period, the engaging in specified procedures, methods or acts.
 
e. Probation.

f. Require a pharmacist or a pharmacist-intern to complete additional education or training.
 
g. Require a pharmacist to successfully complete any reexamination for licensure.
 
h. Order a pharmacist, pharmacist-intern, pharmacy technician, or pharmacy support person to undergo a physical or mental examination.
 
i. Impose civil penalties not to exceed $25,000.
 
j. Issue citation and warning.
 
k. Such other sanctions allowed by law as may be appropriate.

  Close  

Under the Utah State Pharmacy Law, a pharmacy technician may retrieve a new prescription drug order from a voicemail if he/she keeps voicemail order for a pharmacist to review later.

True or False

  Answer  

Under the Utah State Pharmacy Law, a pharmacy technician may retrieve a new prescription drug order from a voicemail if he/she keeps voicemail order for a pharmacist to review later.

Answer: True, [Utah Pharmacy Practice Act Rule R156-17b-601(1)(K)]. The pharmacy technician may retrieve a new prescription drug order from the voicemail if he/she keeps the voicemail order for a pharmacist to review it later.

  Close  

A pharmacy located in Utah that is authorized to provide pharmaceutical care for patients in an institutional setting and whose primary purpose is to provide a physical environment for patients to obtain health care services is classified as:

a. Class A Pharmacy
b. Class B Pharmacy
c. Class C Pharmacy
d. Class D Pharmacy

  Answer  

A pharmacy located in Utah that is authorized to provide pharmaceutical care for patients in an institutional setting and whose primary purpose is to provide a physical environment for patients to obtain health care services is classified as:

a. Class A Pharmacy
b. Class B Pharmacy
c. Class C Pharmacy
d. Class D Pharmacy

Answer: (b) Class B Pharmacy, [Utah Pharmacy Practice Act 58-17b-102 Definition: 11].

Class A Pharmacy: Means a pharmacy located in Utah that is authorized as a retail pharmacy to compound or dispense a drug or dispense a device to the public under a prescription order.

Class B Pharmacy: Means a pharmacy located in Utah that is authorized to provide pharmaceutical care for patients in an institutional setting and whose primary purpose is to provide a physical environment for patients to obtain health care services. It includes closed-door, hospital, clinic, nuclear, and branch pharmacies; and pharmaceutical administration and sterile product preparation facilities.

Class C Pharmacy: Means a pharmacy that engages in the manufacture, production, wholesale, or distribution of drugs or devices in Utah.

Class D pharmacy: Means a nonresident pharmacy.

Class E pharmacy: Means all other pharmacies.

Closed-door pharmacy: Means a pharmacy that provides pharmaceutical care to a defined and exclusive group of patients who have access to the services of the pharmacy because they are treated by or have an affiliation with a specific entity, including a health maintenance organization or an infusion company, but not including a hospital pharmacy, a retailer of goods to the general public, or the office of a practitioner.

  Close  

Where no pharmacist is present in the professional service area a pharmacy is not required to convert to a non−prescription or sundry outlet if the:

I. The pharmacist is absent for a time period of one half hour or less.

II. The pharmacist must be accessible for communication with the remaining pharmacy staff by phone, pager or other device.

III. The pharmacy must indicate that the pharmacist is not available in the professional service area and indicate the period of absence and the time of the pharmacist's return.

a. I only
b. I and II only
c. II and III only
d. All

  Answer  

Where no pharmacist is present in the professional service area a pharmacy is not required to convert to a non−prescription or sundry outlet if the:

I. The pharmacist is absent for a time period of one half hour or less.

II. The pharmacist must be accessible for communication with the remaining pharmacy staff by phone, pager or other device.

III. The pharmacy must indicate that the pharmacist is not available in the professional service area and indicate the period of absence and the time of the pharmacist's return.

a. I only
b. I and II only
c. II and III only
d. All

Answer: All, [Wisconsin Administrative Code Chapter-6 Phar-6.04(3)(c)].

(c). Where no pharmacist is present in the professional service area a pharmacy is not required to convert to a non−prescription or sundry outlet if the following requirements are met:

1. The pharmacist is absent for a time period of one half hour or less.

2. The pharmacist must be accessible for communication with the remaining pharmacy staff by phone, pager or other device.

3. The pharmacy must indicate that the pharmacist is not available in the professional service area and indicate the period of absence and the time of the pharmacist's return.

4. Pharmacy technicians may only perform duties allowed by s. Phar 7.015 (2).

  Close  

A hospital provides outpatient pharmacy services may use the same pharmacy license it used for the hospital inpatient pharmacy.

True or false

  Answer  

A hospital provides outpatient pharmacy services may use the same pharmacy license it used for the hospital inpatient pharmacy.

True or false

Answer: False, [Wiscosin Administrative Code Phar. 6.02(1m)].

a. A pharmacy license authorizes a pharmacy to operate only at the location designated on the license. Licenses may not be transferred to another location.

b. A hospital which has a pharmacy area providing outpatient pharmacy services which is physically separate from, and not contiguous to the area from which inpatient pharmacy services are provided, shall have a pharmacy license for the outpatient phamacy in addition to a license for the inpatient pharmacy.

Any change in pharmacy ownership shall be reported to the board office and the pharmacy license of the former owner returned. A pharmacy license shall be granted to the new pharmacy.

  Close  

Who shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in Delaware?

a. The Office of Controlled Substances
b. The Delaware State Pharmacy Board
c. Bureau of Narcotics and Dangerous Drugs
d. ISMP

  Answer  

Who shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in Delaware?

a. The Office of Controlled Substances
b. The Delaware State Pharmacy Board
c. Bureau of Narcotics and Dangerous Drugs
d. ISMP

Answer: (a), The Office of Controlled Substances, [Uniform Controlled Substances Act 16-47-4798(c)].

The Office of Controlled Substances shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in this State, and to research the prescribing and dispensing of drugs of concern. The PMP shall not interfere with the legal use of a controlled substance or drug of concern. The PMP shall be:

(1). Used to provide information to prescribers, dispensers, and patients to help avoid the illegal use of controlled substances;

(2). Used to assist law enforcement to investigate illegal activity related to the prescribing, dispensing and consumption of controlled substances or drugs of concern; and

(3). Designed to minimize inconvenience to patients and prescribing medical practitioners while effectuating the collection and storage of prescription monitoring information.

  Close